Sat. November 21, 2009
-
Orange County Business Journal
November 21, 2009
Meanwhile, Allergan and others, including rival
Johnson & Johnson, are lining up their arguments against the proposed
tax. "It is a random hit on an easy ...
BNET
November 21, 2009
Johnson & Johnson recently launched Stelara for the treatment of adult patients with moderate to severe plaque psoriasis. ...
Scarlet Scuttlebutt
November 21, 2009
Recently,
Pfizer and
Johnson & Johnson announced they were leaving our fair state, laying off hundreds of people. The aforementioned facts are truly a ...
DiversityBusiness.com (press release)
November 21, 2009
The
Johnson & Johnson Group of Consumer Companies and
Walmart share a mutual commitment to fostering a rich pool of qualified diverse suppliers that bring ...
Reuters
November 21, 2009
A
stock market float by the gastroinestinal specialist, founded in 2006 as a spin-out from
Johnson & Johnson (JNJ.N), could signal an opening in the IPO ...
PR Newswire (press release)
November 19, 2009
Brian Perkins, Corporate Vice President, Johnson & Johnson, and Chair of the Ad Council, unveiled the new site last night at the Ad Council's 56th Annual ...
PR Newswire (press release)
November 19, 2009
Current Leo Burnett Business clients include ACE Limited, BP,
Johnson & Johnson, Manpower, The Options Industry Council and
United Kingdom Trade ...
PR Newswire (press release)
November 19, 2009
Preceding his time at Synthes, Mr. Rolon held various senior regulatory and clinical positions at Johnson & Johnson in their Ethicon, Cordis, ...
Reuters
November 19, 2009
Aegis, which counts
Kellogg's and
Johnson & Johnson among its clients, reported organic revenue down 10.8 percent, with falls of 10.4 percent at its Aegis ...
InjuryBoard.com (blog)
November 19, 2009
Levaquin maker Johnson & Johnson is fighting attempts by plaintiffs to consolidate the first three bellwether levaquin lawsuits in to one trial. ...
FierceBiotech
November 19, 2009
Bayer
healthcare and
Johnson & Johnson have good news to present about their blood-thinner Xarelto--a potential blockbuster that the FDA declined to approve ...
CNNMoney.com (press release)
November 19, 2009
Johnson & Johnson, one of the world's leading consumer goods and
pharmaceutical companies, appointed KIT digital to develop online campaigns for their ...
Huffington Post (blog)
November 19, 2009
When Brian Perkins, who runs all advertising and
marketing for
Johnson & Johnson (this year's Chairman of the advertising council) got up to make his ...
CoStar Group
November 19, 2009
The deals include L'Oreal Cosmetics, which took 24878 square feet at 6100 Waterford; Johnson & Johnson, which has renewed 17376 square feet at 6303 ...
GulfNews
November 19, 2009
Wim Boogaerts, chairman of
Johnson & Johnson Corporate Citizenship Trust -
Middle East (left) and
UAE Minister ...
DesMoinesRegister.com
November 19, 2009
Some of the men who lived in the Atalissa bunkhouse over the past 33 years now live in a bunkhouse located on the Johnson & Johnson Egg Farm in Goldthwaite, ...
Motley Fool
November 19, 2009
Johnson & Johnson and Procter & Gamble are Income
investor choices, and the Fool owns shares of P&G.
Novartis is a
global Gains pick. ...
PR Newswire (press release)
November 18, 2009
... Rapp
Singapore Silver Sunstopper (
Johnson & Johnson) Colenso BBDO Bronze V $100 Virtual Cash Drop (Frucor) Mobile BBDO Proximity Bronze
Gillette uArt ...
American Chronicle
November 18, 2009
RTT News
November 18, 2009
Prior to Depomed, Callahan was director of operations positions at Avocet Medical, Cygnus Therapeutics, Applied Biosystems and Johnson & Johnson Lifescan. ...
Seeking Alpha (blog)
November 18, 2009
Examples of such companies are Johnson & Johnson (JNJ) has regularly hiked dividends for 47 years in a row. The ten-year average dividend growth for the ...
Motley Fool
November 18, 2009
Unilever, Procter & Gamble, and
Johnson & Johnson are all Motley Fool Income
investor picks. Unilever is also a
global Gains choice. ...
Chicago Tribune
November 18, 2009
Companies such as
Johnson & Johnson provide yields similar to Treasurys, and if the
economy improves,
investors could make money on the stock too. ...
TransWorldNews (press release)
November 18, 2009
Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the
health care field worldwide. ...
Huffington Post (blog)
November 18, 2009
Johnson & Johnson has had a buy rating for the past 120 days, though most ratings agencies have not updated their neutral ratings from the summer. ...
Times of India
November 18, 2009
Though the
chemists had claimed of making regular purchases from
Johnson & Johnson healthcare and Pharmaceutical Company, the medical firm's records stated ...
Crain's New York Business
November 18, 2009
Personal care brands like
Johnson & Johnson and over-the-counter drug marketers see October numbers increase thanks to fears over health
epidemic. ...
TheStreet.com
November 18, 2009
Because the stock has been marching higher while Johnson & Johnson has been churning below $63. We'll check in on Johnson & Johnson tomorrow, but today, ...
Drug Store News (blog)
November 18, 2009
17) Drug maker PPD will work with Johnson & Johnson subsidiary Janssen to develop drugs to treat bowel, skin and respiratory illnesses, PPD announced. ...
PR Newswire (press release)
November 16, 2009
The new Pharmacor report entitled Methicillin-Resistant Staphylococcus Aureus finds that Theravance/Astellas's telavancin, Johnson & Johnson/Basilea's ...
San Francisco Chronicle
November 16, 2009
Johnson & Johnson of
New Brunswick, NJ, makers of Purell Instant Hand Sanitizer, wouldn't release sales figures, but demand has been so high that the ...
Reuters
November 16, 2009
Ortho-McNeil, a Johnson & Johnson (JNJ.N) unit, sells extended-release tramadol tablets under the brand name Ultram. Annual US sales of the 100 mg and 200 ...
Chicago Tribune
November 16, 2009
William McComb, who became chief executive in 2006 after 14 years at
Johnson & Johnson, must improve the company's financial health to handle its heavy
debt ...
Richmond Times Dispatch
November 15, 2009
William McComb, who became
CEO in 2006, spent 14 years at
Johnson & Johnson, where he earned a reputation for enhancing brand names. ...
The
New Brunswick,
New Jersey-based
Johnson & Johnson, the world's largest health-products company, said Nov. 3 it will shrink its workforce by as much as ...
Johnson & Johnson, the world's largest health- products company, is among businesses that continue to cut jobs. Government figures on temporary hires are ...
